# K083232: Modification to:Microfuse Bone Void Filler

- Pathway: 510(k) (Traditional)
- Applicant: Globus Medical, Inc.
- Decided: Dec 24, 2008 after 51 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K960978 (1996). 22 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 24 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K071187: Microfuse Bone Void Filler, Globus Medical, Inc. (2007) Summary page 1.
- K082442: Modification to Microfuse Bone Void Filler, Globus Medical, Inc. (2008) Summary page 1.

## Most influential descendants
- K102392: Microfuse Putty and Microfuse ST Mis (2010), 0 descendants of its own

## Indications for use
MicroFuse Tm Bone Void Filler, combined with autograft or bone marrow aspirate, is intended for use in filling bony voids or gaps of the extremities, spine and pelvis that are not intrinsic to the stability of the bony structure. These osseous defects may be surgically created or created from traumatic injury to the bone. MicroFuse TM provides a bone void filler that resorbs and is replaced with bone during the healing process.

Source page: https://510kreport.com/device/K083232
Methodology: https://510kreport.com/methodology